Hypoxia-induced expression of VEGF splice variants and protein in four retinal cell types

Experimental Eye Research

Volumn 116, Issue , 2013, Pages 240-246

  Watkins, William M ^a   McCollum, Gary W ^a   Savage, Sara R ^a   Capozzi, Megan E ^a   Penn, John S ^a   Morrison, David G ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Hypoxia; Splice variants; Vascular endothelial growth factor

Indexed keywords

MESSENGER RNA; VASCULOTROPIN;

ANIMAL CELL; ARTICLE; ASTROCYTE; CELL CULTURE; CELL LYSATE; CELL TYPE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; HYPOXIA; MICROVASCULAR ENDOTHELIAL CELL; MUELLER CELL; NONHUMAN; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; RAT; RETINA CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; STOICHIOMETRY;

HYPOXIA; SPLICE VARIANTS; VASCULAR ENDOTHELIAL GROWTH FACTOR;

ANIMALS; ANIMALS, NEWBORN; ANOXIA; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION, DEVELOPMENTAL; PROTEIN ISOFORMS; RATS; RATS, LONG-EVANS; REAL-TIME POLYMERASE CHAIN REACTION; RETINA; RETINAL DISEASES; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84885126215     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2013.09.014     Document Type: Article

References (59)

1. Aiello L.P., Avery R.L., et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N.Engl. J. Med. 1994, 331(22):1480-1487.
2. Aiello L.P., Northrup J.M., et al. Hypoxic regulation of vascular endothelial growth factor in retinal cells. Arch. Ophthalmol. 1995, 113(12):1538-1544.
3. Aoyagi Y., Oda T., et al. Overexpression of TGF-beta by infiltrated granulocytes correlates with the expression of collagen mRNA in pancreatic cancer. Br. J. Cancer 2004, 91(7):1316-1326.
4. Bai Y., Ma J.X., et al. Müller cell-derived VEGF is a significant contributor to retinal neovascularization. J.Pathol. 2009, 219(4):446-454.
5. Ben-Av P., Crofford L.J., et al. Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: a potential mechanism for inflammatory angiogenesis. FEBS Lett. 1995, 372(1):83-87.
6. Brown D.M., Kaiser P.K., et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N.Engl. J. Med. 2006, 355(14):1432-1444.
7. Detmar M., Brown L.F., et al. Hypoxia regulates the expression of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) and its receptors in human skin. J.Investig. Dermatol. 1997, 108(3):263-268.
8. Ferrara N. Role of vascular endothelial growth factor in regulation of physiological angiogenesis. Am. J. Physiol. Cell Physiol. 2001, 280(6):C1358-C1366.
9. Ferrara N., Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr. Rev. 1997, 18(1):4-25.
10. Ferrara N., Henzel W.J. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem. Biophys. Res. Commun. 1989, 161(2):851-858.
11. Ferrara N., Houck K., et al. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr. Rev. 1992, 13(1):18-32.
12. Foos R.Y. Chronic retinopathy of prematurity. Ophthalmology 1985, 92(4):563-574.
13. Forsythe J.A., Jiang B.H., et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol. 1996, 16(9):4604-4613.
14. Geisen P., McColm J.R., et al. Choroidal endothelial cells transmigrate across the retinal pigment epithelium but do not proliferate in response to soluble vascular endothelial growth factor. Exp. Eye Res. 2006, 82(4):608-619.
15. Hicks D., Courtois Y. The growth and behaviour of rat retinal Müller cells invitro. 1. An improved method for isolation and culture. Exp. Eye Res. 1990, 51(2):119-129.
16. Houck K.A., Ferrara N., et al. The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol. Endocrinol. 1991, 5(12):1806-1814.
17. Huang H., Gandhi J.K., et al. TNFalpha is required for late BRB breakdown in diabetic retinopathy, and its inhibition prevents leukostasis and protects vessels and neurons from apoptosis. Investig. Ophthalmol. Vis. Sci. 2011, 52(3):1336-1344.
18. Hughes S., Yang H., et al. Vascularization of the human fetal retina: roles of vasculogenesis and angiogenesis. Investig. Ophthalmol. Vis. Sci. 2000, 41(5):1217-1228.
19. Jackson J.R., Minton J.A., et al. Expression of vascular endothelial growth factor in synovial fibroblasts is induced by hypoxia and interleukin 1beta. J.Rheumatol. 1997, 24(7):1253-1259.
20. Klekamp J.G., Jarzecka K., et al. Exposure to hyperoxia decreases the expression of vascular endothelial growth factor and its receptors in adult rat lungs. Am. J. Pathol. 1999, 154(3):823-831.
21. Kurihara T., Westenskow P.D., et al. Targeted deletion of Vegfa in adult mice induces vision loss. J.Clin. Investig. 2012, 122(11):4213-4217.
22. Kvanta A., Algvere P.V., et al. Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor. Investig. Ophthalmol. Vis. Sci. 1996, 37(9):1929-1934.
23. Lashkari K., Hirose T., et al. Vascular endothelial growth factor and hepatocyte growth factor levels are differentially elevated in patients with advanced retinopathy of prematurity. Am. J. Pathol. 2000, 156(4):1337-1344.
24. Lopez P.F., Sippy B.D., et al. Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes. Investig. Ophthalmol. Vis. Sci. 1996, 37(5):855-868.
25. Mager E.M., Renzetti G., et al. Growth factors gene expression in the developing lung. Acta Paediatr. 2007, 96(7):1015-1020.
26. Matsubara T.A., Murata T.A., et al. Isolation and culture of rat retinal microvessel endothelial cells using magnetic beads coated with antibodies to PECAM-1. Curr. Eye Res. 2000, 20(1):1-7.
27. McColm J.R., Geisen P., et al. VEGF isoforms and their expression after a single episode of hypoxia or repeated fluctuations between hyperoxia and hypoxia: relevance to clinical ROP. Mol. Vis. 2004, 10:512-520.
28. McGinn S., Poronnik P., et al. Amethod for the isolation of glomerular and tubulointerstitial endothelial cells and a comparison of characteristics with the human umbilical vein endothelial cell model. Nephrology 2004, 9(4):229-237.
29. Michels S., Rosenfeld P.J., et al. Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration twelve-week results of an uncontrolled open-label clinical study. Ophthalmology 2005, 112(6):1035-1047.
30. Miller J.W., Adamis A.P., et al. Vascular endothelial growth factor in ocular neovascularization and proliferative diabetic retinopathy. Diabetes/Metab. Rev. 1997, 13(1):37-50.
31. Neufeld G., Cohen T., et al. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol. 1999, 13(1):9-22.
32. Ng Y.S., Rohan R., et al. Differential expression of VEGF isoforms in mouse during development and in the adult. Dev. Dyn. Off. Publ. Am. Assoc. Anat. 2001, 220(2):112-121.
33. Park J.E., Keller G.A., et al. The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol. Biol. Cell 1993, 4(12):1317-1326.
34. Penn J.S., Madan A., et al. Vascular endothelial growth factor in eye disease. Prog. Retin. Eye Res. 2008, 27(4):331-371.
35. Pertovaara L., Kaipainen A., et al. Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells. J.Biol. Chem. 1994, 269(9):6271-6274.
36. Pierce E.A., Avery R.L., et al. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc. Natl. Acad. Sci. U. S. A. 1995, 92(3):905-909.
37. Plouet J., Schilling J., et al. Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT-20 cells. EMBO J. 1989, 8(12):3801-3806.
38. Provis J.M. Development of the primate retinal vasculature. Prog. Retin. Eye Res. 2001, 20(6):799-821.
39. Risau W. Mechanisms of angiogenesis. Nature 1997, 386(6626):671-674.
40. Robbins S.G., Conaway J.R., et al. Detection of vascular endothelial growth factor (VEGF) protein in vascular and non-vascular cells of the normal and oxygen-injured rat retina. Growth Factors 1997, 14(4):229-241.
41. Robinson C.J., Stringer S.E. The splice variants of vascular endothelial growth factor (VEGF) and their receptors. J.Cell Sci. 2001, 114(Pt 5):853-865.
42. Sappington R.M., Chan M., et al. Interleukin-6 protects retinal ganglion cells from pressure-induced death. Investig. Ophthalmol. Vis. Sci. 2006, 47(7):2932-2942.
43. Schaffer D.B., Palmer E.A., et al. Prognostic factors in the natural course of retinopathy of prematurity. The cryotherapy for retinopathy of prematurity cooperative group. Ophthalmology 1993, 100(2):230-237.
44. Schwarzenbach H., Chakrabarti G., et al. Gonadotropin-mediated regulation of the murine VEGF expression in MA-10 Leydig cells. J.Androl. 2004, 25(1):128-139.
45. Senger D.R., Galli S.J., et al. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983, 219(4587):983-985.
46. Shima D.T., Kuroki M., et al. The mouse gene for vascular endothelial growth factor. Genomic structure, definition of the transcriptional unit, and characterization of transcriptional and post-transcriptional regulatory sequences. J.Biol. Chem. 1996, 271(7):3877-3883.
47. Soker S., Fidder H., et al. Characterization of novel vascular endothelial growth factor (VEGF) receptors on tumor cells that bind VEGF165 via its exon 7-encoded domain. J.Biol. Chem. 1996, 271(10):5761-5767.
48. Stalmans I., Ng Y.S., et al. Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms. J.Clin. Investig. 2002, 109(3):327-336.
49. Stone J., Itin A., et al. Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J.Neurosc. Off. J. Soc. Neurosci. 1995, 15(7 Pt 1):4738-4747.
50. Su X., Sorenson C.M., et al. Isolation and characterization of murine retinal endothelial cells. Mol. Vis. 2003, 9:171-178.
51. Takeuchi H., Bilchik A., et al. c-MET expression level in primary colon cancer: a predictor of tumor invasion and lymph node metastases. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 2003, 9(4):1480-1488.
52. Tang J., Kern T.S. Inflammation in diabetic retinopathy. Prog. Retin. Eye Res. 2011, 30(5):343-358.
53. Vincenti V., Cassano C., et al. Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3. Circulation 1996, 93(8):1493-1495.
54. Weidemann A., Krohne T.U., et al. Astrocyte hypoxic response is essential for pathological but not developmental angiogenesis of the retina. Glia 2010, 58(10):1177-1185.
55. Wheatley C.M., Dickinson J.L., et al. Retinopathy of prematurity: recent advances in our understanding. Arch. Di. Child. Fetal and Neonatal Ed. 2002, 87(2):F78-F82.
56. Zhang W., Liu H., et al. Inflammation and diabetic retinal microvascular complications. J.Cardiovasc. Dis. Res. 2011, 2(2):96-103.
57. Zhong H., Simons J.W. Direct comparison of GAPDH, beta-actin, cyclophilin, and 28S rRNA as internal standards for quantifying RNA levels under hypoxia. Biochem. Biophys. Res. Commun. 1999, 259(3):523-526.
58. Zhou S., Gu L., et al. MDM2 regulates vascular endothelial growth factor mRNA stabilization in hypoxia. Mol. Cell. Biol. 2011, 31(24):4928-4937.
59. Zygalaki E., Kaklamanis L., et al. Expression profile of total VEGF, VEGF splice variants and VEGF receptors in the myocardium and arterial vasculature of diabetic and non-diabetic patients with coronary artery disease. Clin. Biochem. 2008, 41(1-2):82-87.